Avelumab Plus Axitinib Shows Promise in Advanced GIST ...Middle East

News by : (Medscape) -
A phase 2 AXAGIST trial finds that avelumab combined with axitinib achieves durable disease control in patients with advanced gastrointestinal stromal tumours. Medscape News UK

Hence then, the article about avelumab plus axitinib shows promise in advanced gist was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Avelumab Plus Axitinib Shows Promise in Advanced GIST )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار